Compare Hut 8 Corp (HUT) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hut 8 Corp vs Medtronic PLC — how do they compare? Hut 8 Corp trades at $109.06 (market cap $11.36B), while Medtronic PLC trades at $82.63 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 9.4× Hut 8 Corp's market cap, and Medtronic PLC pays a 3.46% dividend while Hut 8 Corp pays none. Which is the better fit depends on your goals.
| HUT | MDT | |
|---|---|---|
Market Cap | $11.36B | $106.61B |
Sector | Technology | Health |
52-Week High | $133.02 | $105.35 |
52-Week Low | $19.45 | $73.75 |
Enterprise Value | $11.63B | $125.36B |
Dividend Yield | — | 3.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hut 8 (HUT) surged 10.37% to $100.93, driven by a major $9.8 billion AI data center lease that fully commercialized its Texas campus, bringing total contracted value to $19.6 billion. Despite negative profitability metrics, the stock shows strong analyst support with 93.75% buy ratings and a $140.78 consensus target. Technical indicators are mixed with neutral overall signals but bullish moving averages, while fundamentals reveal significant revenue growth potential amid current losses.
The outlook remains bullish based on AI infrastructure expansion, though investors face risks from persistent negative margins and high valuation multiples. The company's pivot to hyperscale computing provides substantial revenue visibility, but execution on profitability remains critical for sustained stock appreciation.
Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.
The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
